CNE100003NQ8
CNE100003NQ8
SHANGHAI MEDICILON INC
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 13.97B EUR | 10.84B EUR | 8.38B EUR |
Enterprise Value | 13.66B EUR | 10.78B EUR | 8.52B EUR |
Valuation Multiples | |||
Trailing P/E | -- | -- | -- |
Forward P/E | 47.06x | -- | -- |
Price to Sales | 10.09x | 8x | 6.84x |
Price to Book | 6.98x | 5.41x | 4.28x |
EV/Revenue | 9.87x | 7.95x | 6.95x |
EV/EBITDA | -975.95x | -- | -- |
Price to FCF (P/FCF) | 109.79x | 81.82x | 203.97x |
EV/FCF | 107.3x | 81.32x | 207.21x |
FCF Yield | 0.91% | 1.22% | 0.49% |